ANIXA BIOSCIENCES, INC. Debt Instrument, Convertible, Conversion Price
ANIXA BIOSCIENCES, INC. (ANIX) had Debt Instrument, Convertible, Conversion Price of $0.19 per share as of 2013-11-30, per its 10-K filed 2015-01-29.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2015-01-29
- 2013-11-30: Debt Instrument, Convertible, Conversion Price $0.19.
- 2013-04-30: Debt Instrument, Convertible, Conversion Price $0.15.
- 2012-09-30: Debt Instrument, Convertible, Conversion Price $0.09.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2013-11-30 | $0.19 10-K · filed 2015-01-29 |
| 2013-04-30 | $0.15 10-Q/A · filed 2013-06-19 |
| 2012-09-30 | $0.09 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |